Company news
Oneness Biotech Co., Ltd. (TPEX:4743) news
Oneness Biotech Co., Ltd. news releases on 6ix. Latest, Jul 4, 2022: Oneness Biotech : The Drug Administration of Vietnam has accepted the NDA application…
Press releases & updates
Oneness Biotech : The Drug Administration of Vietnam has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon
July 4, 2022
Oneness Biotech : announces the information about the investor's conference of 2022 Q2.
June 22, 2022
Oneness Biotech : The findings of the MoA studies on Fespixon(ON101) under collaboration with TMU and NYCU have been accepted and published by a renown SCI journal, JID Innovations
June 2, 2022
Oneness Biotech : receives a China patent on antagonistic PDL1 aptamers.
May 26, 2022
Oneness Biotech : The Annual General Shareholders' Meeting approved the removal of non-competition restriction on the newly-elected director.
May 24, 2022
Oneness Biotech : By-election of one director of the board in 2022 shareholders' meeting
May 24, 2022
Oneness Biotech : announce the important resolutions of the 2022 Annual General Shareholders' Meeting
May 24, 2022
Oneness Biotech : received the notification by the international CRO on the unblinded data of FB825 Phase 2a study in moderate-to-severe atopic dermatitis in the U.S.
May 2, 2022
Oneness Biotech : The Food and Drug Administration–Philippines (PFDA) has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon
April 18, 2022
Oneness Biotech : has been invited to present at the "11th Taiwan CEO Week" online investor's conference co-organized by TWSE and QIC
April 11, 2022
Oneness Biotech : receives ISO13485 Medical Devices Quality Management System Certificate.
April 8, 2022
Oneness Biotech : announces the information about the investor's conference of 2022 Q1.
March 25, 2022
Oneness Biotech Co., Ltd. receives an Indonesian patent titled "TOPICAL FORMULATION FOR PROMOTING WOUND HEALING" on Fespixon cream (Research code: ON101).
March 18, 2022
Oneness Biotech : Nanchou manufacturing site received GMP certificate from the FDA Philippines
March 15, 2022
Oneness Biotech : Announcement on the resignation of the Company's institutional director
March 7, 2022
Oneness Biotech : The Malaysia National Pharmaceutical Regulatory Agency has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon
March 4, 2022
Oneness Biotech : The mechanism of action, Phase 3 MRCT results and post-market cases of the DFU new drug, Fespixon have been accepted for an oral presentation at WUWHS 2022
March 1, 2022
Oneness Biotech : Board of Directors resolved to convene the Annual Shareholders' Meeting of 2022.
February 25, 2022
Oneness Biotech Co., Ltd. receives a Korean patent titled "TOPICAL FORMULATION FOR PROMOTING WOUND HEALING" on Fespixon cream (Research code: ON101).
February 22, 2022
Oneness Biotech : The data of SNS812, an anti-Pan-COVID19 siRNA, co-developed by Oneness & MBS and supervised by NTU professors, were published today by EMBO Mol. Medicine
February 21, 2022
Oneness Biotech : receives a Korean patent on the producing recombinant glycoproteins with modified glycosylation.
February 15, 2022
Oneness Biotech : receives an Indian patent on the producing recombinant glycoproteins with modified glycosylation.
February 14, 2022
Oneness Biotech : receives a Korean patent on FB704A, an anti-IL6 fully-human antibody new drug.
January 25, 2022